Interim Reports

InDex Pharmaceuticals Holding AB (publ) interim report January – September 2016

Initial public offering and listing on Nasdaq First North Stockholm Period July – September 2016  Revenues amounted to MSEK 0.0 (0.0)  Operating result amounted to MSEK -6.6 (-7.5)  Result after tax amounted to MSEK -7.4 (-7.2), corresponding to SEK -0.25 per share (-0.24) before and after dilution  Cas...

Read more